Verastem (VSTM) Misses Q2 EPS by 26c

Verastem (NASDAQ: VSTM) reported Q2 EPS of ($1.06), $0.26 worse than the analyst estimate of ($0.80).

For earnings history and earnings-related data on Verastem (VSTM) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• MIND Technology (MIND) Misses Q1 EPS by 5c
• Medtronic completes $550 million Scientia Vascular acquisition